Primerica Reports Record 2025 Net Income & EPS, Boosts Dividend, and Authorizes New $475M Buyback

summarizeSummary

Primerica reported record 2025 financial results with significant increases in net income, EPS, and revenue, driven by strong investment product sales. The company also announced a new $475 million share repurchase program and a higher quarterly dividend.

check_boxKey Events

• Record Net Income and EPS Growth

  Net income for 2025 increased by 60% to $751.2 million, and diluted EPS rose by 67% to $22.91, reflecting strong overall financial performance.

• Robust Revenue and Investment Product Sales

  Total revenues grew by 7% to $3.29 billion, with Investment and Savings Products sales increasing by 24% to $14.93 billion and client asset values growing by 15% to $128.89 billion.

• Increased Shareholder Returns

  The Board authorized a new $475 million share repurchase program through December 31, 2026, replacing the fully utilized $450 million program. The company also declared a quarterly dividend of $1.20 per share for Q1 2026, an increase from the $4.16 total paid in 2025.

• Successful Exit from Senior Health Business

  The company completed the disposal of its Senior Health business as of September 30, 2024, eliminating a prior-year loss from discontinued operations and allowing for greater focus on core segments.

auto_awesomeAnalysis

Primerica, Inc. has filed its annual 10-K report, confirming and detailing its strong financial performance for the fiscal year ended December 31, 2025. The company achieved a significant 60% increase in net income and a 67% rise in diluted earnings per share compared to the prior year. This robust growth was driven by a 7% increase in total revenues and a substantial 24% surge in Investment and Savings Products sales, alongside a 15% growth in client asset values. The company continues its commitment to shareholder returns by authorizing a new $475 million share repurchase program and increasing its quarterly dividend to $1.20 per share, following a 26% increase in total dividends paid in 2025. The successful disposal of the Senior Health business in 2024 also positions the company for a more focused future.